Evidence map›Paper›PMID 35788523›Full record

ArticleSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2022

[Comparative study on Sichuan yak pericardium and Australian cattle pericardium].

Yicong Zuo, Ke Kang, Dapeng Shang, Xiayan Yang, Yao Wu, Qifeng Yu, Xiantao Wen

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yicong ZuoChengdu NewMed Biotechnology Co., Ltd, Chengdu 611139, P. R. China.
Ke KangInstitute of Regulatory Science for Medical Device/College of Biomedical Engineering, Sichuan University, Chengdu 610065, P. R. China.
Dapeng ShangShanghai NewMed Medical Co., Ltd, Shanghai 201321, P. R. China.
Xiayan YangShanghai NewMed Medical Co., Ltd, Shanghai 201321, P. R. China.
Yao WuNational Engineering Research Center for Biomaterials/College of Biomedical Engineering, Sichuan University, Chengdu 610064, P. R. China.
Qifeng YuShanghai NewMed Medical Co., Ltd, Shanghai 201321, P. R. China.
Xiantao WenShanghai NewMed Medical Co., Ltd, Shanghai 201321, P. R. China.
Shanghai Medical Information Center · CNChengdu Medical College · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, as the key raw material of artificial biological heart valve, bovine pericardium is mainly depend on import and has become a "bottleneck" challenge, greatly limiting the development of domestic biological heart valve. Therefore, the localization of bovine pericardium is extremely urgent. In this study, the pericardium of Sichuan yak was compared with that of Australian cattle in terms of fundamental properties and anti-calcification performance. The results demonstrated that the appearance and thickness of yak pericardium were more advantageous than the Australian one. Sichuan yak pericardium and Australian cattle pericardium had comparable performance in shrinkage temperature, mechanical test and anti-calcification test. This study preliminarily verifies the feasibility of substitution of Australian cattle pericardium by Sichuan yak pericardium and promotes the progression of bovine pericardium localization with data support.

Indexed as

BioprosthesisHeart Valve ProsthesisAnimalsAustraliaCattlePericardiumAnti-calcification performanceAustralian cattle pericardiumFundamental propertySichuan yak pericardium

Identifiers

PMID35788523
PMCPMC10950777
OpenAlexW4283830915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.